The publishing firm Wiley says it is investigating a pivotal paper about a controversial public health tool after Retraction Watch reported on a robust critique of the article which highlighted a number of potentially serious flaws with the research.
We’re talking about the Morisky Medication Adherence Scale (MMAS), whose developer, Donald Morisky, has been hitting researchers with hefty licensing fees — or demands to retract — for nearly two decades.
One of the key papers supporting the validity of the MMAS-8 (the second iteration of the MMAS) was a 2008 article by Morisky and colleagues in the Journal of Clinical Hypertension.
Continue reading Publisher investigating paper a lucrative scale is based on following Retraction Watch reporting